| Authors: |
Gordon A; Gastrointestinal & Lymphoma Unit, Royal Marsden Hospital, London and Surrey, UK., Tran A; Gastrointestinal & Lymphoma Unit, Royal Marsden Hospital, London and Surrey, UK., Fong C; Gastrointestinal & Lymphoma Unit, Royal Marsden Hospital, London and Surrey, UK., Cromarty S; Gastrointestinal & Lymphoma Unit, Royal Marsden Hospital, London and Surrey, UK., Piadel K; Gastrointestinal & Lymphoma Unit, Royal Marsden Hospital, London and Surrey, UK., Zhitkov O; Gastrointestinal & Lymphoma Unit, Royal Marsden Hospital, London and Surrey, UK., Leamon B; Gastrointestinal & Lymphoma Unit, Royal Marsden Hospital, London and Surrey, UK., Cafferkey C; Gastrointestinal & Lymphoma Unit, Royal Marsden Hospital, London and Surrey, UK., Davidson M; Gastrointestinal & Lymphoma Unit, Royal Marsden Hospital, London and Surrey, UK., Das P; Royal Derby Hospital, Derby, UK., Petty R; Division of Molecular and Clinical Medicine, School of Medicine, University of Dundee, Dundee, UK., Roques T; Norfolk and Norwich University Hospitals NHS Foundation Trust, Norwich, UK., Hewish M; Royal Surrey County Hospital, Guildford, UK., Morgan C; Department of Clinical Oncology, Velindre Cancer Centre, Cardiff, UK., Waddell T; Department of Medical Oncology, The Christie NHS Foundation Trust, Manchester, UK., Darby S; Weston Park Cancer Centre, Sheffield, UK., Bradshaw A; Northern Centre for Cancer Care, Newcastle Upon Tyne, UK., Rao S; Gastrointestinal & Lymphoma Unit, Royal Marsden Hospital, London and Surrey, UK., Starling N; Gastrointestinal & Lymphoma Unit, Royal Marsden Hospital, London and Surrey, UK., Chau I; Gastrointestinal & Lymphoma Unit, Royal Marsden Hospital, London and Surrey, UK., Cunningham D; Gastrointestinal & Lymphoma Unit, Royal Marsden Hospital, London and Surrey, UK. David.cunningham@rmh.nhs.uk. |
